Attached files

file filename
10-Q - 10-Q - ACCELERON PHARMA INCxlrn-2015630x10q.htm
EX-31.1 - EXHIBIT 31.1 - ACCELERON PHARMA INCxlrn-2015630xexhibit311.htm
EX-31.2 - EXHIBIT 31.2 - ACCELERON PHARMA INCxlrn-2015630xexhibit312.htm


Exhibit 32.1
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report on Form 10-Q of Acceleron Pharma Inc. (the “Company”) for the period ended June 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, that to his or her knowledge:
 
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date: August 6, 2015
By:
/s/ John L. Knopf
 
 
John L. Knopf Ph.D.
 
 
President and Chief Executive Officer
 
 
(Principal Executive Officer)
 
 
Date: August 6, 2015
By:
/s/ Kevin F. McLaughlin
 
 
Kevin F. McLaughlin
 
 
Chief Financial Officer
 
 
(Principal Financial Officer)